Dietary Supplement Contract Manufacturer
& CDMO — Europe.
Your market vision. Our scientific capital.
- EBM formulation from scratch — no house blends, no shared databases
- ISO 9001 · ISO 22000 · ISO 27001 · FDA Registered — audited to 2029
- 100% IP transfer, permanent — your formula, your brand, no licensing fees
Years of R&D
Brands Launched
QA Complaints
Countries Served
Science you can verify.
Our R&D pedigree is documented in stock exchange filings, Tier-1 media, and international awards — not marketing brochures.
University of Cambridge
Cambridge Lab–to–Scale Partner
We scaled micellar technology created by Lycotec Ltd — a spin-off of Cambridge’s Department of Pathology — from laboratory to industrial production. Documented in Adiuvo Investments S.A. annual reports filed with the Warsaw Stock Exchange (GPW).
International Awards 2025
Rome & NCBiR Recognition
International Leader in Scientific Excellence in Dietary Supplement Manufacturing (Palazzo Brancaccio, Rome). Best in Business Award under the honorary patronage of NCBiR — Poland’s National Centre for Research and Development.
Forbes & Proprietary AI
“Algorithm in a Capsule”
Forbes profiled our proprietary AI toxicology verification system — a safety layer that screens every formula for ingredient interactions and cocktail effects. Not generic ChatGPT. Purpose-built, trained on peer-reviewed medical literature.
CEO publications & media features
Olimpia Baranowska, MSc — CEO & Lead Formulation Scientist
We don’t just manufacture.
We publish, lecture, and peer-review.
Lead Formulation Scientist & CEO
Olimpia Baranowska, MSc Eng.
Ph.D. Candidate in Medical Sciences · Gdańsk University of Technology
Publishing scientist, international conference speaker, and peer-reviewer. Featured in Forbes for pioneering the AI-verified toxicology system that screens every formula at Olympia Biosciences™. Scaled micellar technology from a University of Cambridge spin-off (Lycotec Ltd) to industrial production — documented in Warsaw Stock Exchange filings.
We do not own brands.
We build yours.
Here is what nobody tells you before you sign a contract manufacturing dietary supplements agreement: Most supplement CDMOs sell finished products under their own labels — competing directly with you, using the same formulas, the same supply chain, the same production lines. We refused to play that game. Olympia Biosciences™ will never develop or market a consumer brand. Your formula. Your IP. No exceptions.
AI-Verified Safety Layer
A single overlooked interaction can trigger a recall. After our scientists design each formula from scratch, our proprietary AI screens every combination for cocktail effects and toxicological risks.
Medical-Grade Manufacturing
Your patients trust you. That trust cannot survive a contaminated batch. Every production run is verified by HPLC and GC-MS chromatography. Five ISO certifications — because your reputation demands it.
Full IP Transfer. Period.
Imagine investing months in a custom formula — only to discover your manufacturer owns the rights. Every formula we create is transferred to you permanently. No licensing traps. No "house blends."
Why CDMO Selection Is a High-Stakes Decision
The three ways the wrong CDMO destroys your brand.
Before you sign any contract manufacturing agreement, these are the specific failure modes that have ended supplement brands.
Your formula leaks. Your competitor launches first.
Most supplement CDMOs operate their own consumer brands. They use the same formulation scientists, the same databases, the same supply chains. There is no legal or technical barrier preventing your formula from appearing under a different label within 12 months. This is not theory — it is the documented reality of standard CMO contracts.
Our ISO 27001:2023 certified information security and contractual zero-conflict-of-interest policy make this structurally impossible.
One bad batch. Your brand never recovers.
A product recall in the supplement industry costs between €200K and €2M in direct expenses. The reputational damage is permanent. Most generic CMOs do not perform batch-specific HPLC/GC-MS release testing — they rely on Certificate of Conformity from raw material suppliers. That is not verification. That is assumption.
Every batch we release is verified by in-house HPLC and GC-MS analysis. Zero QA complaints since 2009 across 350+ brands.
You launch. Your CDMO cannot keep up.
A successful launch creates demand your manufacturer was never designed to fulfill. Single production lines create single points of failure. A breakdown, a contamination, a regulatory hold — any of these can halt your supply chain permanently and cede your market position to competitors.
Three independent softgel encapsulation lines provide 300% technical redundancy. We have never missed a committed delivery.
Production Infrastructure — Poland, EU
Two specialized manufacturing facilities.
One for dietary supplements and medical food. One for nutricosmetics — cosmetics of clinical significance. Two separate QA chains. One zero-defect culture.
Facility I — Dietary Supplements & FSMP
CDMO Core: Supplements & Medical Food
Our primary GMP-certified manufacturing facility handles the complete supplement production lifecycle — from evidence-based formulation through HPLC/GC-MS quality release. Specializes in dietary supplements and FSMP (Food for Special Medical Purposes) under EU Regulation 2016/128. Three independent softgel lines, clean-room capsule production, and a dedicated analytical QA/QC laboratory.
Facility II — Nutricosmetics
Medical Cosmetics & Beauty-From-Within
A dedicated facility for nutricosmetics — oral and topical cosmetics of clinical significance. Separate production environment, separate analytical chain. Handles beauty-from-within formulations, dermocosmetics, and medical-grade skincare backed by clinical data and formulated under the same evidence-based rigor as our pharmaceutical-grade supplements.
Side-by-side: CDMO vs CMO vs Research Lab
Not all contract manufacturers are the same.
Here is exactly how Olympia Biosciences™ differs — in writing, with specifics.
| Criteria | Research Lab | Generic CMO | Olympia Biosciences™ |
|---|---|---|---|
| Custom formula from scratch | ✓ Yes, lab-scale only | ✗ Pre-made blends only | ✓✓ Full EBM formulation + scale-up |
| Industrial-scale manufacturing | ✗ Outsourced, IP at risk | ✓ Yes, high volume | ✓✓ 5k–500k+ units, HPLC/GC-MS verified |
| Full IP transfer to client | ~ | ✗ Often retains formula rights | ✓✓ 100% permanent, ISO 27001 protected |
| Zero own consumer brands | ~ | ✗ Most CDMOs compete with clients | ✓✓ Contractual zero conflict of interest |
| FSMP / medical food production | ~ | ✗ Rarely | ✓✓ Specialized, lab-grade protocols |
| AI toxicology verification | ✗ | ✗ | ✓✓ Proprietary, Forbes-featured system |
| Quality complaints since 2009 | — | Industry average varies | 0 |
40+ countries · 350+ brands · every industry
Who partners with Olympia Biosciences™
Physicians & Clinics
Scaling Brands
Pharma Groups
Nutraceutical Labels
FMCG & Retail Chains
Biotech Spin-offs
Built to protect your legacy.
For Physicians
Medical-Grade Supplement Manufacturer
Your patients already trust your clinical judgment. We translate your protocols into a stable, clean-label formulation, handle EFSA-compliant labeling, and deliver a finished product. No fillers you wouldn't prescribe. Starting from 5,000 units.
For Brands
Turnkey Scale-Up Manufacturing
We scale production from 5,000 to 500,000+ units with batch-to-batch consistency verified by HPLC and GC-MS. Full Certificates of Analysis for every raw material. Because when your marketing budget is 7-figures, your supply chain cannot be a question mark.
Clinical Focus
FSMP Contract Manufacturing
One wrong claim on a label ends a brand overnight. We navigate the entire compliance landscape (EU regulations, FDA guidelines, GIS notifications) because we have done it hundreds of times. You focus on the science. We handle the bureaucracy.
Innovation
Advanced Delivery Systems
Standard supplement powders die in the stomach. We engineer liposomal encapsulation, nano-micellization, and targeted release systems (Softgel, Enteric HPMC). Backed by real chromatographic data, ensuring active ingredients actually reach the bloodstream.
Production at Scale — Gdynia, Poland
Where precision becomes production.
Three independent softgel encapsulation lines. HPLC/GC-MS batch release. Zero deviations since 2009. This is not capacity for the sake of capacity — it is redundancy engineered so that your launch date is never a manufacturing variable.
capsules per month
independent softgel lines
QA deviations since 2009
We do not work with everyone.
Seventeen years. Zero complaints. Not one. That is not a marketing line — it is a direct mathematical consequence of the projects we refuse.
We will not put our name behind a generic composition that already sits on ten thousand shelves under ten thousand different labels. We will not manufacture with commodity-grade raw materials just because a procurement department wants to shave twelve cents per unit. We will not compress a stability protocol because a launch date was promised before the science was finished.
There is a reason our clients build brands that command premium pricing in highly competitive markets. There is a reason their products survive regulatory scrutiny in jurisdictions where others fail. There is a reason some of them started with a single SKU and now operate across forty countries.
It is not luck. It is what happens when the formulation, the raw materials, the delivery system, and the manufacturing precision are all engineered to be strictly unreplicable. We say no to more projects than we accept. The clients who pass that threshold tend to stay for years.
Proprietary AI Safety System — Forbes Featured
Every formula screened before a single patient sees it.
Our AI toxicology verification system is not ChatGPT. It is purpose-built and trained exclusively on peer-reviewed pharmacological literature. It screens every formula for ingredient interactions, cocktail effects, and toxicological risks — as a final safety gate after our scientists complete R&D.
"Algorithm in a Capsule" — Forbes
Explore Our TechnologyFrom molecule to market.
R&D Discovery
Your clinical insight becomes a stable formula. We test ingredient interactions and verify safety through our proprietary AI.
Your clinical or commercial insight is reverse-engineered into a stable, scalable formula. We audit every active ingredient for sourcing purity, bioavailability data, and known interactions. Our proprietary AI toxicology system performs a final screening pass — an additional safety gate beyond any standard in the industry.
You receive: Proof-of-Concept formula · Ingredient safety dossier · AI interaction report
Scale-Up
From 5k to 500k units. Softgels, blisters, clean-label formulations. Every batch perfectly matches the last.
Pilot batch is scaled to full commercial production on the same validated equipment. PPQ (Process Performance Qualification) ensures batch-to-batch consistency from 5,000 to 500,000+ units. You are never surprised at scale.
You receive: Pilot batch · PPQ validation protocol · Scale-up report
QA / QC
HPLC/GC-MS batch verification and Full Certificate of Analysis for pharmaceutical-grade quality assurance.
Every production batch is released only after HPLC and GC-MS chromatographic analysis confirms active compound concentrations. Full Certificate of Analysis (CoA) issued per batch, covering identity, potency, purity, and microbiological safety.
You receive: HPLC/GC-MS Certificate of Analysis · Stability data · Release documentation
Compliance
We handle GIS notification, EFSA health claims, and export documentation (FSC). You focus on the science.
We handle GIS notification, EFSA health claims compliance, and export documentation (Free Sale Certificate). Your product arrives market-ready in EU, U.S. (FDA), and 40+ international markets. You focus on the brand. We handle the regulatory maze.
You receive: GIS notification · EFSA claim compliance · FSC export documents
Delivery Technologies
Every advanced delivery format. One facility.
We manufacture across the full spectrum of modern supplement delivery — from softgel encapsulation to liposomal nanotechnology.
Therapeutic Axes · Live Research
APPLIED SCIENCE · READY FORMULATIONS & TECHNOLOGIES
Precision Microbiome & Gut-Brain Axis
The Gut-Brain Axis in ADHD: Microbiota Mechanisms and Therapy
Developing scientifically validated microbiome-targeted interventions for ADHD involves addressing the challenges of heterogeneity in clinical outcomes and identifying precise microbial mechanisms. Formulating stable, effective probiotics or synbiotics with demonstrated clinical benefits remains a major hurdle.
View Dossier
Advanced BBB Permeability Solutions
Can Lipid Nanoformulations Unlock the Blood-Brain Barrier?
Lipophilic phytochemicals exhibit poor systemic and brain bioavailability due to rapid metabolism, low solubility, and active efflux at the blood-brain barrier, impeding clinical translation.
View Dossier
Post-GLP-1 Metabolic Optimization
Fixing Ratio Variability in Solid Oral Formulations
Fixed-ratio solid oral formulations are prone to content uniformity failures caused by segregation during handling and compression, exacerbated by moisture-driven changes in material properties. These challenges impact dosing accuracy and lead to potential batch rejection.
View DossierSince 2009 — Gdynia, Poland
Built in Poland. Trusted in 40+ countries.
From a single formulation lab in Gdynia to a dual-facility CDMO serving premium brands on six continents — the same uncompromising commitment to evidence-based science since day one.
Year founded
Production facilities
ISO certifications
QA complaints
Your vision meets our science.
Two capitals. One product.
You bring market intelligence and clinical insight. We bring seventeen years of R&D depth, proprietary AI safety verification, and manufacturing precision that has never produced a single complaint. Together, we engineer products that command premium pricing and survive regulatory scrutiny in any jurisdiction.
Frequently Asked Questions
What does a dietary supplement contract manufacturer do?
What is a Dietary Supplement CDMO in Europe and how does Olympia Biosciences™ differ?
What certifications does Olympia Biosciences™ hold?
Can Olympia Biosciences™ manufacture FSMP (Foods for Special Medical Purposes)?
What is the AI-Verified Safety Layer?
Does Olympia Biosciences™ provide full IP transfer?
What is the difference between a CDMO and a CMO in supplement manufacturing?
Which countries does Olympia Biosciences™ serve as a supplement CDMO?
How long does custom supplement formulation take at Olympia Biosciences™?
What supplement delivery forms does Olympia Biosciences™ manufacture?
Go deeper into our science.
Formulation Technology
Liposomal · Nano-micellar · Softgel
Softgel Manufacturing
100M+ capsules/month · 0 QA complaints
IP & NDA Security
ISO 27001 · Full IP transfer · Iron-clad NDAs
FSMP & Medical Food
EU Regulation 2016/128 compliant
10 Tech Advantages
Why premium brands choose Olympia
CEO Profile
MSc · Cambridge partner · Forbes featured